Founded by a world-class team of scientific experts and business leaders, Entheos Labs in collaboration with Mass General Hospital (MGH), is leveraging AI to discover and develop botanically inspired neuroplastogens to address unmet needs in brain-mind health and longevity.

Entheos Labs is building a next generation-neuroplastogen company with two reinforcing value engines: (1) ET 01, a clinic friendly psychedelic optimized for outpatient delivery, and (2) an exclusive Strategic Alliance with MGH that generates a pipeline of nonscheduled neuroplastogens derived from overlooked entheogenic botanicals from indigenous cultures that can scale operationally and economically.

Entheos Labs

Org chart

Teams

Offices

Entheos Labs

Org chart

Teams

Offices

Related companies